hexoprenaline has been researched along with Respiratory Distress Syndrome in 1 studies
Hexoprenaline: Stimulant of adrenergic beta 2 receptors. It is used as a bronchodilator, antiasthmatic agent, and tocolytic agent.
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A few hours later fulminant acute adult respiratory distress syndrome (ARDS) developed." | 1.28 | [Lesional pulmonary edema associated with tocolysis by hexoprenaline sulfate]. ( Nicole, A; Regamey, C; Rivier, G; Stucki, D, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rivier, G | 1 |
| Nicole, A | 1 |
| Stucki, D | 1 |
| Regamey, C | 1 |
1 other study available for hexoprenaline and Respiratory Distress Syndrome
| Article | Year |
|---|---|
[Lesional pulmonary edema associated with tocolysis by hexoprenaline sulfate].
Topics: Adult; Carbon Dioxide; Cesarean Section; Critical Care; Female; Hexoprenaline; Humans; Hypoxia; Infa | 1992 |